Every article we've published on PharmEasy — results, funding rounds, IPO plans and market commentary. Information only, not advice.
AIOCD Raises Concerns Over Potential Instamart-PharmEasy Partnership for 10-Minute Medicine Delivery The All India Organisation of Chemists and Druggi…
Comprehensive Report on PharmEasy's FY24 Financial Performance Introduction PharmEasy, a leading digital healthcare platform in India, has made signif…
Thyrocare Technologies has expanded its presence in Northern India by acquiring the pathology business of Polo Labs. The acquisition aims to enhance T…
PharmEasy, a leading digital pharmacy, recently secured INR 1,804 Cr ($216.2 Mn) in funding led by the Manipal Group chairman Ranjan Pai's family offi…
The Competition Commission of India (CCI) has given approval for Manipal group chief Ranjan Pai's significant investment in PharmEasy, a rising star i…
Thyrocare, a diagnostics platform owned by PharmEasy, is set to acquire Think Health Diagnostics, based in Chennai to expand its services. The acquisi…
The Competition Commission of India (CCI) has given its nod for the acquisition of stakes in PharmEasy by various entities, notably the Naspers group …
PharmEasy, operating under API Holdings, experienced a notable upswing in operating revenue, exceeding INR 6,000 Cr in the fiscal year concluding on M…
PharmEasy, a major healthtech player, recently appointed Yatharth Bhargova as the new Group CFO of its parent company, API Holdings. He took over in S…
In the rapidly evolving landscape of India's e-pharmacy sector, 1mg, a Tata Digital-owned entity, has emerged as the undisputed leader, surpassing its…
Introduction Pharmeasy, a significant player in India's digital pharmacy landscape, has recently announced its plan to raise INR 3500 Cr through a Rig…
1. Steps taken to improve Profitability by Pharmeasy in Fy23 a) Marketing and growth expenses are reduced as a % of revenue from 7.9% in FY’22 t…
Indicative prices, company research and your enquiries — in your pocket. Get price notes on the names you follow and reach our team from anywhere.
